Trial Phase
Trial Status
Paid Participation
Clear All
37 Chronic Lymphocytic Leukemia Trials Near You
Power is an online platform that helps thousands of Chronic Lymphocytic Leukemia patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerIbrutinib + Rituximab for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
529 Participants Needed
Trial Details
Key Eligibility Criteria
547 Participants Needed
Trial Details
Key Eligibility Criteria
984 Participants Needed
Combination Therapy for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
720 Participants Needed
Acalabrutinib vs Ibrutinib for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
533 Participants Needed
Trial Details
Key Eligibility Criteria
535 Participants Needed
Trial Details
Key Eligibility Criteria
454 Participants Needed
JCAR017 for Chronic Leukemia or Lymphoma
Trial Details
Key Eligibility Criteria
320 Participants Needed
Venetoclax + Obinutuzumab for Leukemia
Trial Details
Key Eligibility Criteria
247 Participants Needed
Vitamin D for Lymphoma
Trial Details
Key Eligibility Criteria
197 Participants Needed
Trial Details
Key Eligibility Criteria
120 Participants Needed
Pirtobrutinib + VR for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
600 Participants Needed
Palbociclib + Chemotherapy for Childhood Leukemia and Lymphoma
Trial Details
Key Eligibility Criteria
12 Participants Needed
CYT-0851 for Cancer
Trial Details
Key Eligibility Criteria
170 Participants Needed
BMF-219 for Blood Cancers
Trial Details
Key Eligibility Criteria
55 Participants Needed
JNJ-75348780 for Lymphoma and Leukemia
Trial Details
Key Eligibility Criteria
147 Participants Needed
Acalabrutinib for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
552 Participants Needed
Zanubrutinib vs Bendamustine + Rituximab for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
590 Participants Needed
Trial Details
Key Eligibility Criteria
640 Participants Needed
Sonrotoclax + Zanubrutinib for Blood Cancers
Trial Details
Key Eligibility Criteria
56 Participants Needed
CAR T-Cell Therapy + Ibrutinib for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
225 Participants Needed
BTKi + Venetoclax for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
100 Participants Needed
Zilovertamab Vedotin for Lymphoma
Trial Details
Key Eligibility Criteria
223 Participants Needed
Ibrutinib + FCR for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
85 Participants Needed
SC291 for B-Cell Malignancies
Trial Details
Key Eligibility Criteria
16 Participants Needed
Lenalidomide + Blinatumomab for Lymphoma
Trial Details
Key Eligibility Criteria
44 Participants Needed
Iopofosine for Waldenstrom Macroglobulinemia
Trial Details
Key Eligibility Criteria
120 Participants Needed
Oral LOXO-305 for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
860 Participants Needed
FT819 for Blood Cancer
Trial Details
Key Eligibility Criteria
54 Participants Needed
CTX112 for B-Cell Cancers
Trial Details
Key Eligibility Criteria
120 Participants Needed
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.